0001209191-22-060596.txt : 20221209
0001209191-22-060596.hdr.sgml : 20221209
20221209195946
ACCESSION NUMBER: 0001209191-22-060596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221121
FILED AS OF DATE: 20221209
DATE AS OF CHANGE: 20221209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Srivastava Deepak
CENTRAL INDEX KEY: 0001868501
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40656
FILM NUMBER: 221455963
MAIL ADDRESS:
STREET 1: C/O TENAYA THERAPEUTICS, INC.
STREET 2: 171 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tenaya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001858848
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813789973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 500
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-865-2066
MAIL ADDRESS:
STREET 1: 171 OYSTER POINT BLVD., SUITE 500
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-21
0
0001858848
Tenaya Therapeutics, Inc.
TNYA
0001868501
Srivastava Deepak
C/O TENAYA THERAPEUTICS, INC.
171 OYSTER POINT BLVD., 5TH FLR.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2022-11-21
4
P
0
230769
2.60
A
372435
I
See Footnote
Common Stock
191666
D
These shares are held directly by The J. David Gladstone Institutes for which the Reporting Person serves as President. The Reporting Person may be deemed to have voting and investment control over the shares. The Reporting Person disclaims beneficial ownership of these shares. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the shares held by The J. David Gladstone Institutes for Section 16 or any other purpose.
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
2022-12-09